Literature DB >> 7736531

Idiotypic cascades after injection of the monoclonal antibody OC125. A study in a mouse model.

B C Schultes1, J Reinsberg, U Wagner, H Schlebusch, H Richter, D Krebs, H J Biersack.   

Abstract

In an animal model, we evaluated the possibility to induce antibodies directed against the tumor-associated antigen CA125 by immunization with the anti-CA125 antibody OC125 via activation of the idiotypic network. Our results show that Balb/c mice, immunized by repeated administrations of F(ab')2-fragments of the OC125 antibody (Ab1), produced anti-idiotypic antibodies (Ab2). The binding of these antibodies to the OC125 could be completely inhibited by the antigen CA125, suggesting that the anti-idiotypic antibodies imitate the original target antigen of the OC125. After induction of these paratope-binding anti-idiotypic antibodies (Ab2 beta), a murine IgG-anti-CA125 (Ab3) response arose in the same mice. The induction of idiotypic cascades offers the possibility of immunization against tumor-associated antigens without using the original antigen and breaking antitumor tolerance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7736531     DOI: 10.1007/bf02789237

Source DB:  PubMed          Journal:  Cell Biophys        ISSN: 0163-4992


  15 in total

1.  Immunotherapy of advanced ovarian carcinomas by activation of the idiotypic network.

Authors:  U A Wagner; P F Oehr; J Reinsberg; S C Schmidt; H W Schlebusch; B Schultes; A Werner; G Prietl; D Krebs
Journal:  Biotechnol Ther       Date:  1992

Review 2.  Idiotypic networks and nature of molecular mimicry: an overview.

Authors:  H Köhler; S Kaveri; T Kieber-Emmons; W J Morrow; S Müller; S Raychaudhuri
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

3.  Idiotypic cascades in cancer patients treated with monoclonal antibody CO17-1A.

Authors:  M Wettendorff; D Iliopoulos; M Tempero; D Kay; E DeFreitas; H Koprowski; D Herlyn
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients.

Authors:  M V Pimm; A C Perkins; N C Armitage; R W Baldwin
Journal:  J Nucl Med       Date:  1985-09       Impact factor: 10.057

5.  Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?

Authors:  H Koprowski; D Herlyn; M Lubeck; E DeFreitas; H F Sears
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

6.  "Sandwich"-type immunoassay of carcinoembryonic antigen in patients receiving murine monoclonal antibodies for diagnosis and therapy.

Authors:  F J Primus; E A Kelley; H J Hansen; D M Goldenberg
Journal:  Clin Chem       Date:  1988-02       Impact factor: 8.327

7.  Antiidiotype antibodies in cancer patients receiving monoclonal antibody to carcinoembryonic antigen.

Authors:  U C Traub; R L DeJager; F J Primus; M Losman; D M Goldenberg
Journal:  Cancer Res       Date:  1988-07-15       Impact factor: 12.701

8.  Monoclonal antiidiotypic antibodies related to a murine oncofetal bladder tumor antigen induce specific cell-mediated tumor immunity.

Authors:  V K Lee; T G Harriott; V K Kuchroo; W J Halliday; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

9.  Idiotype vaccines against human T cell acute lymphoblastic leukemia. I. Generation and characterization of biologically active monoclonal anti-idiotopes.

Authors:  M Bhattacharya-Chatterjee; M W Pride; B K Seon; H Kohler
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

10.  Recurrent idiotopes and internal images.

Authors:  N K Jerne; J Roland; P A Cazenave
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.